The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

High blood pressure is the main modifiable risk factor for preventing cardiovascular events in people who have had a stroke or transient ischaemic attack; however, only approximately one in three ...

From a chatbot that refuses to delete its peers to decades-old promises of frictionless, jobless offices that produced more work, the future keeps arriving with less revolution and more irony. Layer ...

In the world of highly competitive digital platforms, the main attraction for the business is the user's attention. In some ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

The dorsal raphe nucleus (DRN) serotonergic (5-HT) system has been implicated in regulating sleep and motor control; however, its specific role remains controversial. In this study, we found that ...

Introduction In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency ...

Dr. Nooka provides comprehensive guidance on bispecific antibody safety management, emphasizing the predictable chronology of ...

BCMA bispecifics in relapsed myeloma deliver 60–70% responses and year-long PFS, expanding options beyond limited CAR T ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, released a forward-looking technological achievement: the hybrid quantum-classical three-dimensional ...

Key meetings begin this week as Formula 1 and the FIA weighs up driver criticism and potential rule ...

MicroCloud Hologram Inc. plans to develop a quantum-resistant protocol based on a multi-layered hybrid cryptographic architecture, which will introduce a parallel validation mechanism for post-quantum ...